LACOG - Latin American Cooperative Oncology Group· @LACOG_group · X·· 2 天前评分70
正文 · 机器翻译
10月23日，LACOG研究者 Carlos H. Barrios 博士在马德里的 ESMO Congress 2026 上介绍了 DESTINY-Breast05 的健康相关生活质量结果和患者报告结局。
#LACOG #ESMO2026
7 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
539RO按 Rapid oral: Breast cancer, early stage 对上
Patient-reported outcomes (PROs) from DESTINY-Breast05: Health-related quality of life (HRQoL) with trastuzumab Deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (Pts) with high-risk HER2-positive early breast cancer (eBC)
https://esmocongress.esmo.org来源：LACOG - Latin American Cooperative Oncology Group · x.com